Sensei Biotherapeutics Inc (SNSE) — Financial Flexibility Index
Sensei Biotherapeutics Inc (SNSE) has a Financial Flexibility Index of -0.76x as of March 2026. Free cash flow of $-10.73 Million (operating CF $-10.73 Million minus capex $6.00K) represents -1% of total liabilities ($14.19 Million). Check SNSE goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Sensei Biotherapeutics Inc Financial Flexibility Index (2018–2025)
Historical Financial Flexibility Index trend for Sensei Biotherapeutics Inc across 8 annual periods. For the full cash flow conversion analysis, see Sensei Biotherapeutics Inc (SNSE) cash conversion ratio.
Annual Financial Flexibility Index for Sensei Biotherapeutics Inc (2018–2025)
Year-by-year free cash flow to debt coverage for Sensei Biotherapeutics Inc. Explore how well can Sensei Biotherapeutics Inc service its debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -4.74x | $-20.44 Million | $-20.45 Million | $4.31 Million | ▼ -34.9% |
| 2024 | -3.52x | $-24.52 Million | $-24.67 Million | $6.97 Million | ▼ -4.7% |
| 2023 | -3.36x | $-31.84 Million | $-32.02 Million | $9.48 Million | ▼ -29.9% |
| 2022 | -2.59x | $-38.70 Million | $-39.03 Million | $14.97 Million | ▲ +38.5% |
| 2021 | -4.21x | $-28.23 Million | $-30.26 Million | $6.71 Million | ▼ -41.1% |
| 2020 | -2.98x | $-16.50 Million | $-17.70 Million | $5.54 Million | ▼ -2345.4% |
| 2019 | -0.12x | $-8.52 Million | $-8.57 Million | $69.88 Million | ▲ +34.4% |
| 2018 | -0.19x | $-10.28 Million | $-10.31 Million | $55.33 Million | — |